Craneware (CRW) Rating Reiterated by Peel Hunt

Craneware (LON:CRW)‘s stock had its “buy” rating restated by Peel Hunt in a note issued to investors on Friday.

Separately, Berenberg Bank restated a “buy” rating and issued a GBX 3,600 ($47.04) price target on shares of Craneware in a research note on Monday, November 26th.

Shares of LON CRW opened at GBX 2,930 ($38.29) on Friday. Craneware has a 12-month low of GBX 1,170 ($15.29) and a 12-month high of GBX 2,040 ($26.66).

In other Craneware news, insider Keith Neilson purchased 4,848 shares of the business’s stock in a transaction on Friday, September 7th. The shares were bought at an average cost of GBX 3,082 ($40.27) per share, for a total transaction of £149,415.36 ($195,237.63).

Craneware Company Profile

Craneware plc engages in the development, licensing, and ongoing support of computer software for the United States healthcare industry. The company offers patient engagement solutions that enhance patient satisfaction with billing by providing accurate out-of-pocket estimates and mobile-friendly payment plans; reduce bad debt and ineffective paper collections with upfront patient engagement and point-of-service collections; and provide all-payor medical necessity validation and prior authorization coverage to ensure accuracy and prevent denials.

Featured Article: Preferred Stock

Receive News & Ratings for Craneware Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Craneware and related companies with's FREE daily email newsletter.


Leave a Reply

share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit